Abstract
Although rare, rectourethral fistula (RUF) is a morbid pathology most commonly presenting as an iatrogenic defect in patients treated for prostate or rectal cancer. Increasing rates of prostate cancer detection and concurrent use of energy therapies for pelvic malignancies have led to an increased incidence of RUF. An estimated 0.1%-3% of patients undergoing external beam radiation therapy, brachytherapy, and/or cryotherapy for prostate or rectal cancer present with RUF. 1 Hechenbleikner E.M. Buckley J.C. Wick E.C. Acquired rectourethral fistulas in adults: a systematic review of surgical repair techniques and outcomes. Dis Colon Rectum. 2013; 56: 374-383https://doi.org/10.1097/DCR.0b013e318274dc87 Google Scholar Decreasing repair failures and complications of intervention are important when considering treatment approaches.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
